As of 2025-07-03, the EV/EBITDA ratio of Entia Biosciences Inc (ERGO) is -0.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ERGO's latest enterprise value is 0.97 mil USD. ERGO's TTM EBITDA according to its financial statements is -1.16 mil USD. Dividing these 2 quantities gives us the above ERGO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 0.4x | 0.4x |
| Forward P/E multiples | 0.5x - 0.8x | 0.6x |
| Fair Price | (0.05) - (0.04) | (0.05) |
| Upside | -46779.5% - -43344.3% | -46092.4% |
| Date | EV/EBITDA |
| 2025-05-02 | -0.84 |